These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 18339075

  • 1. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [Abstract] [Full Text] [Related]

  • 2. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H, Cooper C, Murphy T, Klein MB.
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [Abstract] [Full Text] [Related]

  • 3. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 4. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [Abstract] [Full Text] [Related]

  • 5. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J.
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [Abstract] [Full Text] [Related]

  • 6. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B.
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [Abstract] [Full Text] [Related]

  • 7. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR, VA HCV-001 Study Group.
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [Abstract] [Full Text] [Related]

  • 8. Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index.
    Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Pinheiro SR, Barbosa DV, Lanzoni VP, Ferraz ML, Silva AE.
    J Viral Hepat; 2010 Jun; 17(6):391-9. PubMed ID: 19758273
    [Abstract] [Full Text] [Related]

  • 9. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
    Khan DA, Fatima-Tuz-Zuhra, Khan FA, Mubarak A.
    J Ayub Med Coll Abbottabad; 2008 Sep; 20(4):122-6. PubMed ID: 19999223
    [Abstract] [Full Text] [Related]

  • 11. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
    Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY.
    Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
    [Abstract] [Full Text] [Related]

  • 12. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P.
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 14. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S, Antonsson L, Westin J, Lagging M.
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [Abstract] [Full Text] [Related]

  • 15. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
    Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK.
    Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
    [Abstract] [Full Text] [Related]

  • 16. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
    Cross TJ, Calvaruso V, Foxton MR, Manousou P, Quaglia A, Grillo F, Dhillon AP, Nolan J, Chang TP, O'Grady J, Heneghan MA, O'Beirne JP, Burroughs AK, Harrison PM.
    J Viral Hepat; 2010 Sep; 17(9):640-9. PubMed ID: 19922441
    [Abstract] [Full Text] [Related]

  • 17. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [Abstract] [Full Text] [Related]

  • 18. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [Abstract] [Full Text] [Related]

  • 19. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F.
    Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
    [Abstract] [Full Text] [Related]

  • 20. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.